Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Potential antidepressant with neuroprotective properties identified at CV Technologies

Oct. 2, 2001

Boehringer Ingelheim presents new AMPA receptor modulators and potential uses thereof

Oct. 1, 2001

Nastech licenses European rights to intranasal morphine

Oct. 1, 2001

New dopamine D4 ligands from Lundbeck and potential therapeutic uses

Sep. 28, 2001

NeoTherapeutics files IND to begin clinical studies with drug targeting severe dementia

Sep. 28, 2001

NIH funds further development of experimental stroke therapy; PNAS article supports new strategy

Sep. 28, 2001

Lundbeck presents several classes of 5-HT1A receptor ligands

Sep. 27, 2001

Alzheimer's Disease Cooperative Study receives research award from NIA

Sep. 27, 2001

Substituted pyridines with the ability to control synaptic transmission

Sep. 26, 2001

Bax inhibitors from ARS associated with improved neuronal survival

Sep. 26, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...